Advances in Metabolic Therapeutics for Obesity, Diabetes and MASH

Ipsos is pleased to be taking part in this webinar hosted by PBSS (Pharmaceutical & BioScience Society International).

Listen in as Ipsos experts talk about the transformative advances in obesity, type 2 diabetes, and MASH. Discover how next-generation therapies and landmark approvals are reshaping patient care, and gain actionable insights into the future of treatment for these complex conditions.

Topics we cover:

• Recent milestones in cardiovascular and metabolic disease
• Key scientific and clinical developments (e.g., GLP-1s, MASH approvals)
• Latest deal and acquisition activity
• Current, next, and future drugs
• Phase 3 and phase 2 molecules: trial designs, MOA, efficacy/safety, distinctive features
• Comparative analysis of assets by therapy area